Concepedia

Christopher Massey

CM

5

Publications

201

Citations

5

H-Index

2019

Active since

Affiliations

The University of Texas Medical Branch at Galveston(Current)

University of Iowa

New York Blood Center

Collaborations Pharmaceuticals (United States)

SRI International

Christopher Massey is an author at The University of Texas Medical Branch at Galveston specializing in antimicrobial resistance, drug resistance, and virology.

Top concepts

Publications per year

2019–2021

5

Publications

5

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates

Gang Ye, Joseph P. Gallant, Jian Zheng et al. · eLife · 2021 · 62 citations · Full text

Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection

Thomas R. Lane, Christopher Massey, Jason E. Comer et al. · PLoS neglected tropical diseases · 2019 · 57 citations · Full text

, , +23

A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques

Paul E. Harris, Trevor Brasel, Christopher Massey et al. · Vaccines · 2021 · 36 citations · Full text

Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig

Thomas R. Lane, Christopher Massey, Jason E. Comer et al. · Antiviral Research · 2020 · 23 citations · Full text

, , +6

The Development of a Novel Nanobody Therapeutic for SARS-CoV-2

Gang Ye, Joseph P. Gallant, Christopher Massey et al. · 2020 · 23 citations · Full text

Rows per page

1–5 of 5